Loading
PRP is a mixture of two inactive digestive enzymes from Propanc Biopharma, intended to slow tumour growth and spread. It is still being prepared for a first trial in people.
PRP is Propanc Biopharma's lead candidate, a formulation of trypsinogen and chymotrypsinogen. The FDA granted it orphan drug designation for the treatment of pancreatic cancer in June 2017. Propanc reports laboratory and dose range-finding studies, a GMP manufacturing process and a bio-analytical assay prepared for a phase 1b first-in-human study in advanced cancer patients, which had not begun when the October 2026 registration statement was filed.
A combination of the pancreatic proenzymes trypsinogen and chymotrypsinogen, the inactive precursors of digestive enzymes, which Propanc Biopharma says produces multiple effects on cancer cells intended to inhibit tumour growth and spread.
1.PRP (Propanc proenzyme therapy) binds its target.
Treatment of pancreatic cancer
FDA orphan drug designation, as stated in the company's registration statement source
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"PRP" OR ABSTRACT:"PRP" OR TITLE:"Propanc proenzyme therapy" OR ABSTRACT:"Propanc proenzyme therapy" OR TITLE:"trypsinogen and chymotrypsinogen" OR ABSTRACT:"trypsinogen and chymotrypsinogen") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about PRP (Propanc proenzyme therapy), not a curated reading list.
Shares Pancreatic ductal adenocarcinoma and the tag pipeline.
Shares Pancreatic ductal adenocarcinoma and the tag pipeline.
Shares Pancreatic ductal adenocarcinoma and the tag pipeline.
Shares Pancreatic ductal adenocarcinoma and the tag pipeline.
Shares Pancreatic ductal adenocarcinoma and the tag pipeline.
Shares Pancreatic ductal adenocarcinoma and the tag pipeline.
Shares Pancreatic ductal adenocarcinoma and the tag pipeline.
Shares Pancreatic ductal adenocarcinoma and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/